Previous 10 | Next 10 |
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results PR Newswire NASHVILLE, Tenn. , Nov. 7, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceutical company, announced today that its product portfolio...
Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...
Cumberland Pharmaceuticals Inc. (CPIX) is expected to report for Q1 2024
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS PR Newswire NASHVILLE, Tenn. , Oct. 31, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceuticals company, announced today that it will releas...
NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE PR Newswire NASHVILLE, Tenn. , Oct. 10, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today a new publication in Antimicrobial Agen...
2023-10-06 13:29:08 ET Gainers: Falcon's Beyond Global (FBYD) +145% . American Oncology Network ( AONC ) +53% . Akso Health Group ( AHG ) +23% . Vigil Neuroscience ( VIGL ) +20% . NuScale Power Corporation ( SMR )...
2023-08-12 04:21:09 ET Cumberland Pharmaceuticals Inc. (CPIX) Q2 2023 Earnings Conference Call August 08, 2023, 04:30 PM ET Company Participants Molly Aggas - IR A.J. Kazimi - CEO Todd Anthony - VP, Organizational Development John Hamm - CFO Conference ...
2023-08-08 17:12:18 ET Cumberland Pharmaceuticals press release ( NASDAQ: CPIX ): Q2 GAAP EPS of $0.06. Revenue of $10.9M (+5.8% Y/Y). $89.4 million in total assets, $52.5 million in total liabilities, and $36.8 million of shareholders' equity at the end of June 2023. ...
Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023 PR Newswire NASHVILLE, Tenn. , Aug. 8, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceutical company, today announced significantly i...
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS PR Newswire NASHVILLE, Tenn. , Aug. 1, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release ...
News, Short Squeeze, Breakout and More Instantly...
Cumberland Pharmaceuticals Inc. Company Name:
CPIX Stock Symbol:
NASDAQ Market:
Cumberland Pharmaceuticals Inc. Website:
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS PR Newswire Growing data shows intravenous ibuprofen is safe and effective for the treatment of pain and fever in adults, children and infants NASHVILLE, Tenn. , Ap...
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results PR Newswire 2023 highlights include expanded FDA approval and new study publications NASHVILLE, Tenn. , March 5, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a sp...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...